期刊
DIGESTIVE AND LIVER DISEASE
卷 55, 期 4, 页码 519-526出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2022.11.003
关键词
Chronic hepatitis B; Chronic hepatitis D; HBV epidemiology; HDV epidemiology; HBV vaccine; HBV and migration
This study examined the epidemiology of HBV in a large single center cohort over the past two decades, revealing changes in the characteristics and trends of HBV infection. Differences were observed between Italian and non-Italian immigrants, with age and gender playing important roles in the infected population. The prevalence of chronic HBV decreased, while HBeAg-negative infection increased. The incidence of cirrhosis declined, except for patients with ongoing HDV infection, particularly among non-Italian immigrants.
Background & Aim: HBV epidemiology is highly heterogeneous and rapidly evolving worldwide: we stud-ied its last two-decades dynamics in a large single center cohort. Methods: In all consecutive HBsAg-positive subjects firstly admitted (20 0 0-2019) at the Pisa-University -Hospital Hepatology-Referral-Center, demographic, virologic and clinical variables were analyzed by ad-mission decade (20 0 0-20 09 vs 2010-2019) and origin (Italian vs non-Italian natives). Results: Of 2003, 1878 (93.7%) subjects were eligible: 1798(95.7%) with HBV-chronic [126(7%) HDV, 72(4%) HCV, 11(0.6%) HIV co-infected] and 80(4.3%) HBV-primary infections (93.7% Italians). Among 1589(88.4%) mono-infected, 496(31.2%) were immigrants, younger than Italians [34.0(5.1-77.1)-52.5(10.0- 87.2) years], with female prevalence [204/496(41.1%)-340/1093(31.1%); p < 0.001] increasing overtime (14.6-45.0%; p < 0.001). Italians aged across decades [50.3(11.1-87.2)-56.2(10.0-86.7) years; p < 0.001], HBeAg-positivity remained stable (12.3-14.5%) and acute hepatitis increased (4.0-8.0%; p = 0.003). CHB declined [439/721(60.9%)-320/868(36.9%); p < 0.001] whereas HBeAg-negative infection increased [277/626(44.2%)-538/755(71.3%); p < 0.001]. Cirrhosis declined [195/721(27.0%)-125/868(14.4%); p < 0.001], except in anti-HDV-patients [93/126(73.8%); 42(45.1%) non-Italians], younger than HBV-mono-infected (47.4-57.6 years; p < 0.001). Conclusion: Effective preventive health care policies and immigration flows account for increasing preva-lence of HBeAg-negative infection across the last two decades. Antiviral therapy mitigated disease pro-gression in aging Italian CHB but not in CHD patients, mainly young immigrants, emphasizing the unmet need of effective CHD therapies; HBeAg-positive CHB and acute hepatitis B persist in non-vaccinated Ital-ian adults, prompting vaccination in the elderly with risky behaviors. (c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据